Pihlajalinna
10.75
EUR
+0.47 %
Corporate customer
PIHLIS
NASDAQ Helsinki
Health Care Providers
Health Care
8,701 following
Income statement
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 424.0 | 487.8 | 518.6 | 508.7 | 577.7 | 690.3 | 720.0 | 702.4 | 679.2 | 543.8 | 567.4 |
growth-% | 15.1 % | 6.3 % | -1.9 % | 13.6 % | 19.5 % | 4.3 % | -2.4 % | -3.3 % | -19.9 % | 4.3 % | |
EBITDA | 33.3 | 44.8 | 47.9 | 52.5 | 63.0 | 54.4 | 72.6 | 100.3 | 100.5 | 87.6 | 90.9 |
EBIT (adj.) | 23.8 | 19.5 | 25.4 | 24.2 | 33.4 | 18.9 | 30.3 | 48.7 | 50.4 | 38.8 | 42.3 |
EBIT | 19.1 | 13.2 | 10.2 | 18.2 | 28.0 | 9.0 | 20.7 | 46.8 | 49.0 | 37.5 | 41.2 |
Profit before taxes | 17.4 | 9.5 | 6.3 | 13.8 | 24.2 | 1.6 | 8.4 | 37.1 | 41.1 | 29.7 | 33.6 |
Net income | 9.5 | 3.4 | 3.4 | 8.8 | 20.1 | 9.6 | 5.9 | 26.4 | 30.3 | 23.3 | 26.4 |
EPS (adj.) | 0.64 | 0.30 | 0.79 | 0.63 | 1.10 | 0.82 | 0.56 | 1.14 | 1.29 | 1.06 | 1.22 |
growth-% | -53.8 % | 165.8 % | -20.2 % | 75.3 % | -25.8 % | -31.5 % | 103.7 % | 13.3 % | -17.9 % | 14.6 % | |
Dividend | 0.16 | 0.10 | 0.00 | 0.20 | 0.30 | 0.00 | 0.07 | 0.42 | 0.44 | 0.44 | 0.46 |
Dividend ratio | 34.9 % | 65.7 % | 51.2 % | 33.8 % | 27.1 % | 35.7 % | 32.6 % | 42.4 % | 39.1 % |
Profitability and return on capital
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
---|---|---|---|---|---|---|---|---|---|---|---|
EBITDA-% | 7.9 % | 9.2 % | 9.2 % | 10.3 % | 10.9 % | 7.9 % | 10.1 % | 14.3 % | 14.8 % | 16.1 % | 16.0 % |
EBIT-% (adj.) | 5.6 % | 4.0 % | 4.9 % | 4.8 % | 5.8 % | 2.7 % | 4.2 % | 6.9 % | 7.4 % | 7.1 % | 7.4 % |
EBIT-% | 4.5 % | 2.7 % | 2.0 % | 3.6 % | 4.8 % | 1.3 % | 2.9 % | 6.7 % | 7.2 % | 6.9 % | 7.3 % |
ROE | 3.1 % | 3.0 % | 8.4 % | 17.5 % | 7.9 % | 4.3 % | 16.6 % | 16.8 % | 12.6 % | 13.9 % | |
ROI | 4.9 % | 3.1 % | 5.6 % | 8.7 % | 2.1 % | 3.9 % | 9.1 % | 9.7 % | 7.3 % | 8.0 % |
Valuation
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
---|---|---|---|---|---|---|---|---|---|---|---|
Share price (EUR) | 13.70 | 10.00 | 15.30 | 9.38 | 12.64 | 8.52 | 7.06 | 10.75 | 10.75 | 10.75 | 10.75 |
Shares | 20.6 | 22.6 | 22.6 | 22.6 | 22.6 | 22.5 | 22.6 | 22.4 | 22.4 | 22.4 | 22.4 |
Market cap | 282.4 | 226.2 | 346.1 | 212.1 | 285.6 | 192.1 | 159.7 | 241.1 | 241.1 | 241.1 | 241.1 |
Enterprise value | 353.6 | 390.6 | 540.2 | 406.9 | 480.3 | 579.6 | 533.4 | 585.0 | 562.7 | 559.5 | 541.7 |
EV/S | 0.8 | 0.8 | 1.0 | 0.8 | 0.8 | 0.8 | 0.7 | 0.8 | 0.8 | 1.0 | 1.0 |
EV/EBITDA | 10.6 | 8.7 | 11.3 | 7.8 | 7.6 | 10.6 | 7.4 | 5.8 | 5.6 | 6.4 | 6.0 |
EV/EBIT (adj.) | 14.8 | 20.0 | 21.3 | 16.8 | 14.4 | 30.7 | 17.6 | 12.0 | 11.2 | 14.4 | 12.8 |
EV/EBIT | 18.5 | 29.5 | 53.2 | 22.4 | 17.2 | 64.5 | 25.8 | 12.5 | 11.5 | 14.9 | 13.2 |
P/E (adj.) | 21.4 | 33.7 | 19.4 | 14.9 | 11.5 | 10.4 | 12.6 | 9.4 | 8.3 | 10.1 | 8.8 |
P/E | 29.9 | 65.7 | 102.4 | 24.0 | 14.2 | 20.1 | 39.4 | 10.0 | 8.6 | 10.6 | 9.1 |
P/B | 2.8 | 1.9 | 3.4 | 1.9 | 2.4 | 1.5 | 1.1 | 1.4 | 1.3 | 1.3 | 1.2 |
P/S | 0.7 | 0.5 | 0.7 | 0.4 | 0.5 | 0.3 | 0.2 | 0.3 | 0.4 | 0.4 | 0.4 |
Dividend yield | 1.2 % | 1.0 % | 2.1 % | 2.4 % | 1.0 % | 3.9 % | 4.1 % | 4.1 % | 4.3 % | ||
Equity ratio | 35.7 % | 29.9 % | 24.2 % | 26.0 % | 26.8 % | 18.6 % | 22.0 % | 26.0 % | 29.0 % | 28.6 % | 31.0 % |
Gearing ratio | 67.6 % | 126.0 % | 182.9 % | 169.6 % | 158.8 % | 315.4 % | 244.4 % | 193.9 % | 162.6 % | 178.6 % | 154.3 % |
Quarter data
Q4/23 | 2023 | Q1/24 | Q2/24 | Q3/24 | Q4/24e | 2024e | Q1/25e | Q2/25e | |
---|---|---|---|---|---|---|---|---|---|
Revenue | 182.9 | 720.0 | 183.2 | 174.8 | 164.0 | 180.4 | 702.4 | ||
EBITDA | 11.6 | 72.6 | 25.7 | 22.6 | 26.3 | 25.7 | 100.3 | ||
EBIT | -2.0 | 20.7 | 12.7 | 9.5 | 11.8 | 12.8 | 46.8 | ||
Profit before taxes | -6.0 | 8.4 | 10.2 | 6.7 | 9.5 | 10.7 | 37.1 | ||
Net income | -5.2 | 5.9 | 7.2 | 4.8 | 6.3 | 8.1 | 26.4 |